Page 2 - Alto Investors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alto investors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alto Investors Today - Breaking & Trending Today

Perceptive Advisors Llc Acquires 8,374 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc purchased 8,374 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was bought at an average price of $3.25 per share, for a total transaction of $27,215.50. Following the completion of the acquisition, the insider now owns […] ....

Verition Fund Management , Perceptive Advisors Llc , Aldeyra Therapeutics Inc , Vanguard Group Inc , Capital Partners , Pricet Rowe Associates Inc , Aldeyra Therapeutics , Get Free Report , Advisors Llc , Alto Investors , Fund Management , Scavenger Receptor , Aldeyra Therapeutics Daily ,

JPMorgan Chase & Co. Trims AnaptysBio (NASDAQ:ANAB) Target Price to $28.00

JPMorgan Chase & Co. Trims AnaptysBio (NASDAQ:ANAB) Target Price to $28.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dennis Mulroy , Daniel Faga , Stifel Nicolaus , Piper Sandler , Anaptysbio Inc , First Light Asset Management , Millennium Management , Jpmorgan Chase Co , Eventide Asset Management , Free Report , Moderate Buy , Bio Stock Down , Get Free Report , Light Asset Management , Asset Management , Palo Alto Investors , Alto Investors , Anaptysbio Daily ,

Parsons Capital Management Inc. RI Sells 24,241 Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD)

Parsons Capital Management Inc. RI reduced its stake in Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 949,841 shares of the company’s stock after selling 24,241 shares during […] ....

Maged Shenouda , Blackrock Inc , Parsons Capital Management Inc , Relmada Therapeutics Inc , Renaissance Technologies , Exchange Commission , Millennium Management , Parsons Capital Management , Relmada Therapeutics , Free Report , Capital Management , Alto Investors , Sigma Investments , Chuck Ence , Relmada Therapeutics Daily , Nasdaq Rlmd , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

AnaptysBio (NASDAQ:ANAB) Stock Price Down 4.6% Following Analyst Downgrade

AnaptysBio (NASDAQ:ANAB) Stock Price Down 4.6% Following Analyst Downgrade
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Paulf Lizzul , Stifel Nicolaus , Piper Sandler , Ericj Loumeau , Jpmorgan Chase Co , Anaptysbio Company Profile , Securities Exchange Commission , Anaptysbio Inc , Great Point Partners , Pricet Rowe Associates Inc , Fisher Asset Management , Get Free Report , Exchange Commission , Asset Management , Alto Investors , Capital Advisors , Point Partners , Anaptysbio Daily ,

Nevro (NYSE:NVRO) Stock Price Down 4.8%

Nevro (NYSE:NVRO) Stock Price Down 4.8%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Robertw Baird , Pricet Rowe Associates Inc , Nomura Holdings Inc , Canaccord Genuity Group , Barclays Plc , Nevro Company Profile , Nevro Corp , Wells Fargo Company , Goldman Sachs Group Inc , Get Free Report , Genuity Group , Stock Down , Sachs Group , Alto Investors , Senza Omnia , Nevro Daily ,